Cas no 1259277-49-0 (tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate)

tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate structure
1259277-49-0 structure
Product Name:tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate
CAS No:1259277-49-0
MF:C12H24N2O2
MW:228.331163406372
MDL:MFCD26743821
CID:1222248
PubChem ID:68007523
Update Time:2025-10-29

tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate Chemical and Physical Properties

Names and Identifiers

    • 2-Methyl-2-propanyl [(1R,2S)-2-(aminomethyl)cyclohexyl]carbamate
    • rel-N-[(1R,2S)-2-(Aminomethyl)cyclohexyl]-carbamic acid 1,1-dimethylethyl ester
    • tert-Butyl [(1R,2S)-2-(aminomethyl)cyclohexyl]carbamate
    • Carbamic acid, N-[(1R,2S)-2-(aminomethyl)cyclohexyl]-, 1,1-dimethylethyl ester, rel(Racemic)
    • tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate
    • trans-(Aminomethyl)-1-(Boc-amino)-cyclohexane
    • 852661-35-9
    • trans-tert-Butyl-2-(aminomethyl)cyclohexylcarbamate
    • tert-butyl trans-2-(aminomethyl)cyclohexylcarbamate
    • 1259277-49-0
    • tert-Butyl((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
    • tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
    • tert-Butyl ((1R,2S)-2-(aminomethyl)cyclohexyl)carbamate
    • F18537
    • MFCD26743821
    • NYPPQRSVUJQKTO-VHSXEESVSA-N
    • SCHEMBL10007332
    • tert-butyl N-[(1R,2S)-2-(aminomethyl)cyclohexyl]carbamate
    • A889892
    • PS-18470
    • Carbamic acid, N-[(1R,2S)-2-(aminomethyl)cyclohexyl]-, 1,1-dimethylethyl ester, rel-
    • MDL: MFCD26743821
    • Inchi: 1S/C12H24N2O2/c1-12(2,3)16-11(15)14-10-7-5-4-6-9(10)8-13/h9-10H,4-8,13H2,1-3H3,(H,14,15)/t9-,10+/m0/s1
    • InChI Key: NYPPQRSVUJQKTO-VHSXEESVSA-N
    • SMILES: O(C(C)(C)C)C(N[C@@H]1CCCC[C@H]1CN)=O

Computed Properties

  • Exact Mass: 228.18392
  • Monoisotopic Mass: 228.183778013g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 4
  • Complexity: 236
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 2
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.2
  • Topological Polar Surface Area: 64.4?2

Experimental Properties

  • PSA: 64.35

tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
C383963-10mg
tert-Butyl ((1R,2S)-rel-2-(Aminomethyl)cyclohexyl)carbamate
1259277-49-0
10mg
$ 70.00 2022-06-06
TRC
C383963-50mg
tert-Butyl ((1R,2S)-rel-2-(Aminomethyl)cyclohexyl)carbamate
1259277-49-0
50mg
$ 230.00 2022-06-06
TRC
C383963-100mg
tert-Butyl ((1R,2S)-rel-2-(Aminomethyl)cyclohexyl)carbamate
1259277-49-0
100mg
$ 340.00 2022-06-06
Chemenu
CM294526-100mg
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
100mg
$238 2023-02-03
Chemenu
CM294526-250mg
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
250mg
$403 2023-02-03
Chemenu
CM294526-500mg
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
500mg
$722 2023-02-03
Chemenu
CM294526-1g
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
1g
$1084 2023-02-03
Chemenu
CM294526-5g
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
5g
$3251 2023-02-03
Chemenu
CM294526-1g
tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate
1259277-49-0 95%
1g
$809 2021-06-15
eNovation Chemicals LLC
Y1210077-100mg
tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate
1259277-49-0 97%
100mg
$255 2024-07-21

Additional information on tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate

Comprehensive Guide to tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate (CAS No. 1259277-49-0)

tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate (CAS No. 1259277-49-0) is a specialized organic compound widely used in pharmaceutical research and fine chemical synthesis. This compound, often referred to as a protected amine derivative, plays a crucial role in the development of novel drug candidates and bioactive molecules. Its unique structural features, including the tert-butyl carbamate (Boc) protecting group and the trans-cyclohexyl backbone, make it a valuable intermediate in medicinal chemistry.

The growing interest in tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate is driven by its applications in peptide synthesis and small-molecule drug discovery. Researchers frequently search for "Boc-protected cyclohexylamine derivatives" or "CAS 1259277-49-0 suppliers" to source this compound for their projects. Its stability under various reaction conditions and compatibility with common coupling reagents make it a preferred choice for solid-phase peptide synthesis (SPPS) and combinatorial chemistry.

From a chemical perspective, tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate exhibits several noteworthy properties. The trans configuration of the cyclohexyl ring provides enhanced stereochemical control in synthetic applications, while the Boc protecting group offers selective deprotection under mild acidic conditions. These characteristics have made it particularly valuable in the synthesis of GPCR-targeting compounds and CNS-active molecules, which are currently hot topics in pharmaceutical research.

The market for tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate has seen steady growth, paralleling the increasing demand for custom pharmaceutical intermediates. Many researchers looking for "high purity CAS 1259277-49-0" or "Boc-aminomethylcyclohexane derivatives" are focused on developing new treatments for neurological disorders and metabolic diseases. The compound's versatility allows for its use in creating prodrug formulations and targeted delivery systems, addressing current challenges in drug bioavailability.

In synthetic applications, tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate serves as a key building block for chiral auxiliaries and asymmetric catalysts. Its structural rigidity contributes to the development of compounds with improved pharmacokinetic profiles, a major focus area in modern drug design. The presence of both primary amine and carbamate functionalities enables diverse chemical modifications, making it valuable for creating structure-activity relationship (SAR) libraries.

Quality control of tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate typically involves advanced analytical techniques such as HPLC, NMR spectroscopy, and mass spectrometry. Researchers often inquire about "CAS 1259277-49-0 analytical data" or "tert-butyl carbamate derivative specifications" to ensure compound purity for sensitive applications. The pharmaceutical industry particularly values batches with ≥98% purity for lead optimization studies.

Recent scientific literature highlights innovative uses of tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate in bioconjugation chemistry and proteolysis-targeting chimera (PROTAC) development. These cutting-edge applications align with current trends in targeted protein degradation and precision medicine, explaining the growing number of searches for "Boc-cyclohexylamine applications in drug discovery". The compound's stability makes it suitable for high-throughput screening platforms.

From a regulatory standpoint, tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate is classified as a research chemical with no significant restrictions. However, proper handling procedures should be followed, as with all laboratory chemicals. The compound's non-hygroscopic nature and good solubility in common organic solvents contribute to its popularity in both academic and industrial settings.

The future outlook for tert-butyl N-[trans-2-(aminomethyl)cyclohexyl]carbamate remains positive, particularly in the field of peptidomimetic drug development. As researchers continue to explore "new applications of Boc-protected amines" and "innovative synthetic routes to cyclohexyl derivatives", this compound is likely to maintain its importance in medicinal chemistry. Its role in developing next-generation therapeutics positions it as a valuable asset in the pharmaceutical researcher's toolkit.

Recommended suppliers
Hebei Liye chemical Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hebei Liye chemical Co.,Ltd
Suzhou Genelee Bio-Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Genelee Bio-Technology Co., Ltd.
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.